Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 98 (25), e15949

The Role of CXCR3 and Its Ligands CXCL10 and CXCL11 in the Pathogenesis of Celiac Disease

Affiliations

The Role of CXCR3 and Its Ligands CXCL10 and CXCL11 in the Pathogenesis of Celiac Disease

Mahrokh Haghbin et al. Medicine (Baltimore).

Abstract

The chemokine receptor CXCR3 and its ligands CXCL10 and CXCL11 have been suggested to give rise to the most relevant chemokine axis able to facilitate the entrance of immune cells into inflamed tissues and be activated in different inflammatory disorders, such as celiac disease (CD).The aim of this study was to investigate the expression level of CXCR3, CXCL10, and CXCL11 genes in celiac patients compared to healthy controls. Both cohorts have been recruited from the Iranian population.In this case-control study, biopsy specimens were collected from 71 celiac patients (60.5% female) and 90 control subjects (57% female) during 2016. Total RNA was extracted and mRNA expression levels of CXCR3, CXCL10, and CXCL11 genes were investigated by SYBR green qPCR.Based on qPCR and relative quantification method, the mRNA expression levels of CXCR3, CXCL10, and CXCL11 were significantly higher in duodenal biopsies of celiac patients compared to healthy controls in the study population (P = .038, P = .021, and P = .012 respectively).The result of this study showed that CXCR3/CXCL10/CXCL11 signaling axis is overexpressed in the small intestinal mucosa of CD patients compared to controls. This finding might explain the specific enrollment of the main cell populations that infiltrate the epithelium.

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
CXCL10, CXCL11, and CXCR3 mRNA levels in the duodenum. (A) Expression levels of CXCL10 (P = .038); (B) expression levels of CXCL11 (P = .021); (C) expression levels of CXCR3 (P = .012).
Figure 2
Figure 2
Heatmaps of CXCL10, CXCL11, and CXCR3 mRNA levels in the duodenum. Patients are ordered by groups (A), sex (B) and age (C).

Similar articles

See all similar articles

Cited by 2 articles

References

    1. Ehsani-Ardakani M, Nejad M, Villanacci V, et al. Gastrointestinal and non-gastrointestinal presentation in patients with celiac disease. Arch Iran Med 2013;16:78. - PubMed
    1. Karinen H, Kärkkäinen P, Pihlajamäki J, et al. Gene dose effect of the DQB1∗ 0201 allele contributes to severity of coeliac disease. Scand J Gastroenterol 2006;41:191–9. - PubMed
    1. Louka A, Sollid L. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003;61:105–17. - PubMed
    1. Ciclitira P. AGA technical review on celiac sprue. Gastroenterology 2001;120:1526–40. - PubMed
    1. Green P, Cellier C. Celiac disease. N Engl J Med 2007;357:1731–43. - PubMed
Feedback